News

Keep up with the latest news from the NCI Center for Biomedical Informatics and Information Technology (CBIIT) and the data science communities.

In a recent study, NCI’s Dr. Haoyu Zhang describes CT-SLEB—a powerful and computationally scalable method for generating more precise polygenic risk scores across a range of ancestral groups (including Latino, African American, East Asian, and South Asian).

If you’re using data science to do genomics research for preventing, detecting, and treating cancer across diverse populations, see if this NCI-supported funding opportunity is for you.

The PLCO Atlas allows investigators to browse and access germline genetic association data from the PLCO Screening Study via the Genome-Wide Association Study Explorer.

Researchers seeking potential targets for treating childhood cancers now have an even better tool for the job. Check out the latest enhancements to the NCI Childhood Cancer Data Initiative’s (CCDI’s) Molecular Targets Platform.

NCI-funded researchers validated a genome-wide artificial intelligence technology that could help in early detection of hepatocellular carcinoma—the most common type of liver cancer.

CCDI additions include molecular characterization data from childhood cancer patients of racial and ethnic diversity.

Data analysis of the DNA, RNA, protein, and phosphoprotein in lung adenocarcinoma cells connected molecular features of tumors with patient survivability. This study allowed researchers to better predict prognosis and treatment in lung cancer patients.

Explore the newly released pediatric data set that includes information on DNA/RNA sequencing, methylation arrays, and deidentified clinical reports.

The latest update to the Childhood Cancer Data Catalog includes website improvements and the addition of the database of Genotypes and Phenotypes (dbGaP).

A new precision medicine platform combines machine learning with sophisticated analysis to help researchers mine chromosomal alterations linked to cancer.